Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  12:35PM ET
0.9151
Dollar change
+0.0134
Percentage change
1.49
%
Index- P/E- EPS (ttm)-0.73 Insider Own72.95% Shs Outstand166.40M Perf Week-1.71%
Market Cap152.27M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float45.01M Perf Month-5.17%
Enterprise Value157.82M PEG- EPS next Q- Inst Own0.08% Short Float0.20% Perf Quarter11.60%
Income-2.73M P/S- EPS this Y- Inst Trans0.01% Short Ratio0.74 Perf Half Y-92.21%
Sales0.00M P/B- EPS next Y- ROA-17.24% Short Interest0.09M Perf YTD5.26%
Book/sh-3.19 P/C422.97 EPS next 5Y- ROE-62.50% 52W High15.00 -93.90% Perf Year-92.37%
Cash/sh0.00 P/FCF- EPS past 3/5Y-175.18% - ROIC- 52W Low0.56 62.77% Perf 3Y-91.09%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility7.09% 7.34% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-610.86% Oper. Margin- ATR (14)0.08 Perf 10Y-
Dividend Ex-DateFeb 13, 2023 Quick Ratio0.04 Sales Y/Y TTM- Profit Margin- RSI (14)38.41 Recom-
Dividend Gr. 3/5Y- - Current Ratio0.04 EPS Q/Q-1113.92% SMA20-4.51% Beta- Target Price-
Payout- Debt/Eq- Sales Q/Q- SMA50-6.20% Rel Volume0.11 Prev Close0.90
Employees2 LT Debt/Eq- Earnings- SMA200-87.88% Avg Volume123.80K Price0.92
IPODec 23, 2021 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume7,089 Change1.49%
Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company focuses on creating a fair healthcare ecosystem, to make advance predictive, preventive, and precision medicine accessible and affordable. The company is headquartered in Kuala Lumpur, Malaysia.